SCHEDULE OF REVENUES, OPERATING EXPENSES AND OPERATING INCOME (LOSS) BY REPORTABLE SEGMENT |
SCHEDULE OF REVENUES, OPERATING EXPENSES AND OPERATING INCOME (LOSS) BY REPORTABLE SEGMENT
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nine Months
Ended September 30, 2024 |
|
|
|
($
in thousands) |
|
|
|
Healthcare
IT |
|
|
Medical
Practice Management |
|
|
Unallocated
Corporate Expenses |
|
|
Total |
|
Net revenue |
|
$ |
71,603 |
|
|
$ |
10,995 |
|
|
$ |
- |
|
|
$ |
82,598 |
|
Operating expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Direct operating costs |
|
|
37,699 |
|
|
|
8,140 |
|
|
|
- |
|
|
|
45,839 |
|
Selling and marketing |
|
|
4,785 |
|
|
|
24 |
|
|
|
- |
|
|
|
4,809 |
|
General and administrative |
|
|
6,923 |
|
|
|
1,392 |
|
|
|
3,812 |
|
|
|
12,127 |
|
Research and development |
|
|
2,768 |
|
|
|
- |
|
|
|
- |
|
|
|
2,768 |
|
Depreciation and amortization |
|
|
10,638 |
|
|
|
247 |
|
|
|
- |
|
|
|
10,885 |
|
Loss
on lease terminations, unoccupied lease charges and restructuring costs |
|
|
505 |
|
|
|
- |
|
|
|
- |
|
|
|
505 |
|
Loss on lease terminations, unoccupied lease charges and restructuring costs |
|
|
505 |
|
|
|
- |
|
|
|
- |
|
|
|
505 |
|
Total
operating expenses |
|
|
63,318 |
|
|
|
9,803 |
|
|
|
3,812 |
|
|
|
76,933 |
|
Operating income (loss) |
|
$ |
8,285 |
|
|
$ |
1,192 |
|
|
$ |
(3,812 |
) |
|
$ |
5,665 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months
Ended September 30, 2024 |
|
|
|
($
in thousands) |
|
|
|
Healthcare
IT |
|
|
Medical
Practice Management |
|
|
Unallocated
Corporate Expenses |
|
|
Total |
|
Net revenue |
|
$ |
24,302 |
|
|
$ |
4,244 |
|
|
$ |
- |
|
|
$ |
28,546 |
|
Operating expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Direct operating costs |
|
|
12,445 |
|
|
|
2,975 |
|
|
|
- |
|
|
|
15,420 |
|
Selling and marketing |
|
|
1,368 |
|
|
|
7 |
|
|
|
- |
|
|
|
1,375 |
|
General and administrative |
|
|
2,321 |
|
|
|
481 |
|
|
|
1,576 |
|
|
|
4,378 |
|
Research and development |
|
|
800 |
|
|
|
- |
|
|
|
- |
|
|
|
800 |
|
Depreciation and amortization |
|
|
3,159 |
|
|
|
82 |
|
|
|
- |
|
|
|
3,241 |
|
Loss
on lease terminations, unoccupied lease charges and restructuring costs |
|
|
67 |
|
|
|
- |
|
|
|
- |
|
|
|
67 |
|
Loss
on lease terminations, unoccupied lease charges and restructuring costs |
|
|
67 |
|
|
|
- |
|
|
|
- |
|
|
|
67 |
|
Total
operating expenses |
|
|
20,160 |
|
|
|
3,545 |
|
|
|
1,576 |
|
|
|
25,281 |
|
Operating income (loss) |
|
$ |
4,142 |
|
|
$ |
699 |
|
|
$ |
(1,576 |
) |
|
$ |
3,265 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nine Months
Ended September 30, 2023 |
|
|
|
($
in thousands) |
|
|
|
Healthcare
IT |
|
|
Medical
Practice Management |
|
|
Unallocated
Corporate Expenses |
|
|
Total |
|
Net revenue |
|
$ |
78,531 |
|
|
$ |
10,112 |
|
|
$ |
- |
|
|
$ |
88,643 |
|
Operating expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Direct operating costs |
|
|
46,003 |
|
|
|
7,840 |
|
|
|
- |
|
|
|
53,843 |
|
Selling and marketing |
|
|
7,503 |
|
|
|
26 |
|
|
|
- |
|
|
|
7,529 |
|
General and administrative |
|
|
8,466 |
|
|
|
1,362 |
|
|
|
6,690 |
|
|
|
16,518 |
|
Research and development |
|
|
3,523 |
|
|
|
- |
|
|
|
- |
|
|
|
3,523 |
|
Depreciation and amortization |
|
|
10,013 |
|
|
|
269 |
|
|
|
- |
|
|
|
10,282 |
|
Loss on lease terminations and unoccupied lease charges |
|
|
430 |
|
|
|
- |
|
|
|
- |
|
|
|
430 |
|
Loss on lease terminations, unoccupied lease charges and restructuring costs |
|
|
430 |
|
|
|
- |
|
|
|
- |
|
|
|
430 |
|
Total
operating expenses |
|
|
75,938 |
|
|
|
9,497 |
|
|
|
6,690 |
|
|
|
92,125 |
|
Operating income (loss) |
|
$ |
2,593 |
|
|
$ |
615 |
|
|
$ |
(6,690 |
) |
|
$ |
(3,482 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months
Ended September 30, 2023 |
|
|
|
($
in thousands) |
|
|
|
Healthcare
IT |
|
|
Medical
Practice Management |
|
|
Unallocated
Corporate Expenses |
|
|
Total |
|
Net revenue |
|
$ |
25,592 |
|
|
$ |
3,688 |
|
|
$ |
- |
|
|
$ |
29,280 |
|
Operating expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Direct operating costs |
|
|
15,369 |
|
|
|
2,891 |
|
|
|
- |
|
|
|
18,260 |
|
Selling and marketing |
|
|
2,329 |
|
|
|
8 |
|
|
|
- |
|
|
|
2,337 |
|
General and administrative |
|
|
2,719 |
|
|
|
466 |
|
|
|
2,297 |
|
|
|
5,482 |
|
Research and development |
|
|
1,260 |
|
|
|
- |
|
|
|
- |
|
|
|
1,260 |
|
Depreciation and amortization |
|
|
3,814 |
|
|
|
89 |
|
|
|
- |
|
|
|
3,903 |
|
Loss on lease terminations and unoccupied lease charges |
|
|
8 |
|
|
|
- |
|
|
|
- |
|
|
|
8 |
|
Loss on lease terminations, unoccupied lease charges and restructuring costs |
|
|
8 |
|
|
|
- |
|
|
|
- |
|
|
|
8 |
|
Total
operating expenses |
|
|
25,499 |
|
|
|
3,454 |
|
|
|
2,297 |
|
|
|
31,250 |
|
Operating income (loss) |
|
$ |
93 |
|
|
$ |
234 |
|
|
$ |
(2,297 |
) |
|
$ |
(1,970 |
) |
|